Dr. Ilia Murtazashvili (Chair)
Dr. Louis Picard
Dr. Paul Nelson
Dr. Wesley Rohrer (Graduate School of Public Health)
Organizational technology can be defined as the sum total of man-made continuances or develop processes that alter, refine, or create new goods and services delivered by organizations (Neuby, 2016). In the context of HIV/AIDS service delivery, organizational technology includes human resource management, funding streams, technology, processes, etc. As organizations seek to achieve their objectives, it is important that they engage with stakeholders in order to advance the science and technology of HIV/AIDS research but also to make the case as to why combating the epidemic is a win on the individual, household, and national levels. In this paper, six Nigerian organizations are assessed in terms of how public health services are delivered but also in regards to the leadership styles being employed, funding capacity, evidence-based management approaches, information flow, and their interconnected nature to other organizations and stakeholders. This mixed-method study utilizes a structured phenomenological approach and a survey to assess how organizations are equipped in reaching key populations. Moreover, this research looks at the inner workings of the organization as it relates to organizational behavior, employee motivation, and interpersonal relationships. The findings of this study reveal that an evidence-based management (EBMgt) approach to HIV/AIDS can be a panacea to service delivery as long as organizations have streamlined and effective processes, capacity to scale impact, and sustainable funding. Furthermore, organizations that successfully embed EBMgt in their operations have different leadership styles that cater to the varied needs of their employees and a public health delivery approach grounded in shared vision and values.
In recent decades the structure of national and global economies has undergone a significant shift, characterized as financialization whereby economic, social and political life are being increasingly shaped by financial actors and motives. The central objective of this research is to examine the impact of financialization on the development and use of pharmaceuticals in three areas of global health significance: (1) the “recycling” of antiretroviral drugs for HIV prevention (2) the search for effective treatments and vaccine for Ebola Virus Disease, and (3) the development of solutions for the growing global threat of antimicrobial resistance. This research requires an innovative interdisciplinary approach that brings together expertise in understanding how the worlds of finance and pharmaceuticals work and interact, with insight into how global health problems and solutions then play out in the real world. There has to date been relatively little research exploring these intersections. For each of these areas, the project will assemble in-depth case studies of pharmaceutical solutions, linking research on “upstream” financial factors affecting their development with clinical, epidemiological and social realities “downstream”.
The COVID-19 pandemic is affecting lives and exposing weaknesses in health systems across the globe. The importance of health governance in delivering proper and effective services worldwide cannot be overemphasized. It has become apparent that the old ways – vertical and centralized methods of governance – of leadership are not the most effective during the COVID-19 pandemic. As such, there is a need for newer and more innovative methods – collective action and adaptation to change – of ensuring that healthcare can be delivered effectively amid the ongoing chaos and ambiguity.
NGOs have also successfully mitigated the effects of the pandemic by introducing / incorporating healthy behaviors into public messages (washing of hands and social distancing), spearheading advocacy efforts, and serving as the link between the local communities and bilateral/multilateral donors. These coordinated efforts have helped in reducing the spread of virus which has led to lower morbidity rates. Furthermore, Africa has been able to escape the heavy impact of the pandemic due to its adherence to isolation measures coupled with preventive guidelines, public mandates, and bans on domestic/international travel. This paper seeks to explore why effective health governance is important during the pandemic, the roles of NGOs, and lessons learnt thus far.
This paper provides insight into the various challenges women face, their roles in leadership and how they have advanced over the years in Africa against these odds. It is becoming more apparent than ever that female leadership in Africa is predetermined by the state of women’s affairs in a country. More women seem to be breaking beyond society’s expectations of their potential being limited to the home front. Reports have shown that when women are able to reach their full potential – equal participation in the economy as their male counterparts – global GDP can increase and in sub-Saharan Africa specifically, the GDP can increase by 27%, or $0.7 trillion, when the gap is closed. According to a report by McKinsey, women make up over half the world’s population, but only 37% of them are in the workforce. With that in mind, many initiatives and programs have been established to combat gender inequality, providing more opportunities for women to join the workforce. These initiatives often have a common theme which is to empower women and make them qualified leaders in different sectors through scholarships, skill acquisition, grants, competitions, mentorship, etc. Despite the gains that have been made by African female leaders, there is still more work to be done. Boosting the number of African women in leadership roles – that have power and influence – would require a culture shift in regard to societal expectations and norms